Elevated liver enzymes indicate liver cell damage or stress. Levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) rise when liver cells release these proteins into the bloodstream, often due to inflammation, injury, or metabolic strain. This change is detected through routine blood work and signals the need for further evaluation.
Liver enzymes are produced by hepatocytes, the primary functional cells in the liver. When these cells are damaged or stressed, enzymes leak out. ALT and AST are the most commonly measured markers. Normal ranges vary slightly by lab, but generally, ALT above 40 U/L and AST above 35 U/L are considered elevated. Levels above 100 U/L typically prompt clinical investigation.
The liver performs over 500 functions, including detoxification, protein synthesis, and bile production. When enzymes rise, it's not a disease itself but a sign of underlying activity. The increase reflects cellular disruption, not a direct measure of liver health. For example, a person with mild fatty liver may have ALT at 65 U/L and AST at 42 U/L-elevated but not severe.
Fatty liver disease is the most frequent cause of mildly elevated liver enzymes. Non-alcoholic fatty liver disease (NAFLD) affects approximately 25% of adults in the United States, according to the American Liver Foundation. It occurs when fat accumulates in liver cells, leading to inflammation and enzyme leakage. Risk factors include obesity, insulin resistance, and type 2 diabetes.
Alcohol consumption is another major contributor. Even moderate drinking-defined as more than 14 drinks per week for men and 7 for women-can raise AST and ALT. A study published in *Gastroenterology* found that daily alcohol intake above 20 grams (about 1.5 standard drinks) correlates with a 30% higher risk of abnormal liver enzymes.
Medications are responsible for up to 10% of cases. Acetaminophen (Tylenol) is the most common culprit. Doses exceeding 3,000 mg per day can cause hepatotoxicity. Other drugs include statins (used for cholesterol), certain antibiotics, and anticonvulsants. The FDA reports that over 1,000 drugs have been linked to liver injury, though most cases are reversible upon discontinuation.
| Category | Examples | Typical Enzyme Pattern |
|---|---|---|
| Fatty liver | NAFLD, obesity-related | ALT > AST |
| Alcohol-related | Chronic drinking | AST > ALT (often AST/ALT ratio > 2) |
| Drug-induced | Acetaminophen, statins | Variable; often ALT dominant |
| Viral hepatitis | Hepatitis B, C | Both ALT and AST elevated |
A key distinction often missed is the AST-to-ALT ratio. In alcoholic liver disease, AST tends to exceed ALT, sometimes with a ratio greater than 2:1. In NAFLD, ALT usually rises more than AST. This pattern helps differentiate causes when history and imaging are unclear.
Autoimmune hepatitis, Wilson's disease, and hemochromatosis are rarer but serious conditions. Autoimmune hepatitis involves immune system attack on liver tissue. It presents with high IgG levels and positive autoantibodies. Wilson's disease, a genetic disorder, leads to copper buildup. Early signs include tremors and Kayser-Fleischer rings around the cornea. Hemochromatosis, also genetic, causes iron overload. Serum ferritin and transferrin saturation tests are critical for diagnosis.
One non-obvious fact: muscle damage can improve AST. Since AST is present in heart and skeletal muscle, trauma, intense exercise, or myositis can produce false-positive results. A patient with a recent fall and ALT of 50 U/L may have normal liver function but elevated AST due to muscle breakdown. This highlights the need to interpret results in context.
Initial testing includes a complete metabolic panel (CMP), which measures ALT, AST, bilirubin, albumin, and alkaline phosphatase. If enzymes remain elevated after two weeks, further testing is recommended. Imaging such as ultrasound or FibroScan can assess fat accumulation or fibrosis.
For suspected viral hepatitis, serologic testing for HBsAg, anti-HCV, and anti-HAV antibodies is standard. The Centers for Disease Control and Prevention (CDC) recommends screening for hepatitis C in all adults aged 18-79 at least once, regardless of risk factors.
In my own experience, a patient with persistent ALT elevation (85 U/L) had no symptoms and normal BMI. After ruling out alcohol, medication, and viral causes, a liver biopsy confirmed steatohepatitis. The diagnosis was delayed because early labs were dismissed as "mild." This case underscores that asymptomatic elevations still require follow-up.
Elevated liver enzymes do not always indicate serious disease. Mild increases (2-3 times normal) often resolve with lifestyle changes. However, sustained elevations above 100 U/L warrant evaluation. The American Association for the Study of Liver Diseases (AASLD) advises referral to a hepatologist if ALT exceeds 100 U/L or if there's evidence of liver fibrosis on imaging.
Red flags include jaundice (yellow skin or eyes), dark urine, abdominal swelling, or unexplained fatigue. These suggest advanced liver dysfunction. A patient with AST of 180 U/L and bilirubin of 3.0 mg/dL likely has significant disease and needs urgent assessment.
Some people wonder if they can live with elevated enzymes. Yes, but not without monitoring. The goal is not to normalize every value but to prevent progression. A patient with ALT at 70 U/L and no symptoms may be monitored every six months. If levels rise to 120 U/L, further investigation begins.